How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific.
Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer.
This episode is sponsored by AcuityMD.
Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.